Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

P3 Health Partners (PIII) Return on Sales (2020 - 2025)

P3 Health Partners (PIII) has disclosed Return on Sales for 6 consecutive years, with 152.33% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Return on Sales fell 15204.0% year-over-year to 152.33%, compared with a TTM value of 0.37% through Sep 2025, down 10.0%, and an annual FY2024 reading of 0.21%, up 13657.0% over the prior year.
  • Return on Sales was 152.33% for Q3 2025 at P3 Health Partners, down from 95.34% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.07% in Q2 2024 and bottomed at 152.33% in Q3 2025.
  • Average Return on Sales over 5 years is 21.36%, with a median of 0.31% recorded in 2024.
  • Peak annual rise in Return on Sales hit 12675bps in 2025, while the deepest fall reached -15204bps in 2025.
  • Year by year, Return on Sales stood at 0.48% in 2021, then tumbled by -333bps to 2.06% in 2022, then surged by 44bps to 1.16% in 2023, then surged by 71bps to 0.33% in 2024, then tumbled by -45385bps to 152.33% in 2025.
  • Business Quant data shows Return on Sales for PIII at 152.33% in Q3 2025, 95.34% in Q2 2025, and 0.12% in Q1 2025.